Riverhead Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $22K | Hold |
270
| – | – | ﹤0.01% | 1465 |
|
|
2019
Q2 | $20K | Sell |
270
-13
| -5% | -$963 | ﹤0.01% | 1495 |
|
|
2019
Q1 | $26K | Buy |
283
+64
| +29% | +$5.88K | ﹤0.01% | 1463 |
|
|
2018
Q4 | $16K | Sell |
219
-1,571
| -88% | -$115K | ﹤0.01% | 1472 |
|
|
2018
Q3 | $157K | Sell |
1,790
-575
| -24% | -$50.4K | 0.01% | 1275 |
|
|
2018
Q2 | $233K | Buy |
2,365
+1,565
| +196% | +$154K | 0.01% | 1008 |
|
|
2018
Q1 | $95K | Buy |
+800
| New | +$95K | ﹤0.01% | 1351 |
|